We are live on ! Find out more
TCM

Tang Capital Management Portfolio holdings

AUM $1.97B
1-Year Est. Return 125.1%
This Fund
S&P 500
This Quarter Est. Return
-0.55%
1 Year Est. Return
+125.1%
3 Year Est. Return
+474.48%
5 Year Est. Return
+595.08%
10 Year Est. Return
+2,831.44%
AUM
$1.51B
AUM Growth
+$111M
Cap. Flow
+$272M
Cap. Flow %
17.99%
Top 10 Hldgs %
37.54%
Holding
194
New
40
Increased
63
Reduced
17
Closed
11

Top Buys

Rank Stock Value
1
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$40.7M
2
RLAY icon
Relay Therapeutics
RLAY
+$24.5M
3
BIOA
BioAge Labs
BIOA
+$22.7M
4
LEGN icon
Legend Biotech
LEGN
+$18.6M
5
REPL icon
Replimune Group
REPL
+$18.2M

Top Sells

Rank Stock Value
1
ITOS
iTeos Therapeutics
ITOS
+$18.8M
2
RVNC
Revance Therapeutics, Inc.
RVNC
+$13M
3
IMNM icon
Immunome
IMNM
+$10.5M
4
ANIP icon
ANI Pharmaceuticals
ANIP
+$7.61M
5
CNTA
Centessa Pharmaceuticals
CNTA
+$6.4M

Sector Composition

Rank Sector Weight
1 Healthcare 94.65%
2 Technology 1.65%
3 Communication Services 1.35%
4 Consumer Discretionary 0.56%
5 Financials 0.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VZ icon
126
Verizon
VZ
$196B
$1.23M 0.08%
30,877
+10,476
+51% +$442K
TXN icon
127
Texas Instruments
TXN
$261B
$1.23M 0.08%
6,568
+2,366
+56% +$473K
KO icon
128
Coca-Cola
KO
$375B
$1.23M 0.08%
19,714
+7,341
+59% +$479K
UAL icon
129
United Airlines
UAL
$42.1B
$1.2M 0.08%
12,392
+8,520
+220% +$720K
NFLX icon
130
Netflix
NFLX
$309B
$1.2M 0.08%
13,440
+9,170
+215% +$755K
NKE icon
131
Nike
NKE
$61.9B
$1.19M 0.08%
15,789
+6,250
+66% +$491K
XOM icon
132
ExxonMobil
XOM
$634B
$1.19M 0.08%
11,053
+4,049
+58% +$474K
ULTA icon
133
Ulta Beauty
ULTA
$24.3B
$1.17M 0.08%
+2,699
New +$1.05M
UNH icon
134
UnitedHealth
UNH
$370B
$1.17M 0.08%
2,308
+886
+62% +$503K
JNJ icon
135
Johnson & Johnson
JNJ
$625B
$1.15M 0.08%
7,959
+2,944
+59% +$456K
PFE icon
136
Pfizer
PFE
$153B
$1.14M 0.08%
42,908
+17,170
+67% +$466K
AXP icon
137
American Express
AXP
$230B
$1.13M 0.07%
3,799
+2,798
+280% +$804K
INTC icon
138
Intel
INTC
$513B
$1.12M 0.07%
55,997
+19,425
+53% +$438K
BA icon
139
Boeing
BA
$185B
$1.11M 0.07%
+6,294
New +$988K
AMZN icon
140
Amazon
AMZN
$2.96T
$1.11M 0.07%
5,071
+3,907
+336% +$799K
OPRX icon
141
OptimizeRx
OPRX
$133M
$1.08M 0.07%
+221,200
New +$1.24M
OABI icon
142
OmniAb
OABI
$447M
$1.06M 0.07%
300,000
– –
ALL icon
143
Allstate
ALL
$67.5B
$1.03M 0.07%
5,319
+4,059
+322% +$788K
ATRA icon
144
Atara Biotherapeutics
ATRA
$76.1M
$1M 0.07%
75,196
– –
HRL icon
145
Hormel Foods
HRL
$13.8B
$996K 0.07%
+31,741
New +$995K
TMUS icon
146
T-Mobile US
TMUS
$190B
$995K 0.07%
4,509
+3,438
+321% +$782K
HPE icon
147
Hewlett Packard
HPE
$70.5B
$990K 0.07%
+46,391
New +$979K
GE icon
148
GE Aerospace
GE
$384B
$986K 0.07%
5,911
+4,528
+327% +$808K
PAYX icon
149
Paychex
PAYX
$42.7B
$978K 0.06%
+6,973
New +$990K
CLX icon
150
Clorox
CLX
$12.7B
$977K 0.06%
6,014
+4,778
+387% +$782K
4 5
6
7 8

Similar funds

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
RMCM
Reynders McVeigh Capital Management Boston, Massachusetts $1.98B AUM 23.37% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
SC
Syon Capital San Francisco, California $1.99B AUM 22.67% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BC
Blackhill Capital Morristown, New Jersey $1.94B AUM 18.09% 1-Year Est. Return
FFH
Fairfax Financial Holdings Toronto, Ontario, Canada $1.94B AUM 27.76% 1-Year Est. Return

Tang Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Tang Capital Management held 194 positions worth $1.51B, up 8% from $1.4B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tang Capital Management deployed $272M of net new capital in Q4 2024, opening 40 new positions and adding to 63 existing holdings. Its largest new stake was BioAge Labs: 1,318,361 shares worth $7.63M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, down from 96% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was iTeos Therapeutics, an estimated $18.8M trimmed.

  • Tang Capital Management's largest Q4 2024 buy was BioAge Labs: 1,318,361 shares worth $7.63M.
  • Tang Capital Management added most to Lakefront Biotherapeutics American Depositary Shares in Q4 2024, an estimated $40.7M increase.
  • Tang Capital Management's biggest Q4 2024 reduction was iTeos Therapeutics, cutting an estimated $18.8M.
  • Tang Capital Management fully exited Revance Therapeutics, Inc. in Q4 2024, selling an estimated $13M.
  • Tang Capital Management's ten largest holdings make up 38% of its $1.51B portfolio in Q4 2024.
  • Tang Capital Management opened 40 new positions and closed 11 in Q4 2024.
  • Tang Capital Management's portfolio value rose 8% quarter-over-quarter to $1.51B.

Based on Tang Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.